The Current Ratio as of November 2024 (TTM) for IVERIC bio, Inc. (ISEE) is 18.63

According to IVERIC bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.63. This represents a change of 25.14% compared to the average of 14.88 of the last 4 quarters.

IVERIC bio, Inc. (ISEE) Historical Current Ratio (quarterly & annually)

How has ISEE Current Ratio performed in the past?

The mean historical Current Ratio of IVERIC bio, Inc. over the last ten years is 14.57. The current 18.63 Current Ratio has changed 12.68% with respect to the historical average. Over the past ten years (40 quarters), ISEE's Current Ratio was at its highest in in the March 2014 quarter at 40.94. The Current Ratio was at its lowest in in the December 2016 quarter at 4.49.

IVERIC bio, Inc. (ISEE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of IVERIC bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IVERIC bio, Inc. (ISEE) Average Current Ratio

How has ISEE Current Ratio performed in the past?

The current Current Ratio of IVERIC bio, Inc. (ISEE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IVERIC bio, Inc. (ISEE) Current Ratio vs. Peers

How is ISEE’s Current Ratio compared to its peers?

IVERIC bio, Inc.’s Current Ratio is greater than Blueprint Medicines Corporation (3.32), greater than Amylyx Pharmaceuticals, Inc. (4.55), less than Karuna Therapeutics, Inc. (19.31), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than Immunovant, Inc. (7.61), greater than Akero Therapeutics, Inc. (17.25), greater than Madrigal Pharmaceuticals, Inc. (5.98), greater than Apellis Pharmaceuticals, Inc. (4.36), greater than 89bio, Inc. (11.66), greater than Pliant Therapeutics, Inc. (10.26), greater than Arcellx, Inc. (4.29), greater than Stoke Therapeutics, Inc. (5.09), greater than Roivant Sciences Ltd. (10.43), greater than Krystal Biotech, Inc. (7.97), less than Prometheus Biosciences, Inc. (31.04), less than Viking Therapeutics, Inc. (36.47), greater than Intercept Pharmaceuticals, Inc. (4.22), less than Terns Pharmaceuticals, Inc. (32.99), greater than Reata Pharmaceuticals, Inc. (6.75),

Build a custom stock screener for IVERIC bio, Inc. (ISEE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IVERIC bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IVERIC bio, Inc. (ISEE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IVERIC bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.